4-Substitutedphthalazines and phthalazinones: Synthesis, characterization and β-adrenergic blocking activity

Medicinal Chemistry Research

Volumn 22, Issue 3, 2013, Pages 1057-1064

  Abouzid, Khaled A M ^a   Khalil, Nadia A ^a   Ahmed, Eman M ^a  

^a Ain Shams University   (Egypt)

Author keywords

Adrenergic blockers; Arylpiperazine; Phthalazines; Phthalazinones

Indexed keywords

4 (4 BROMOPHENYL)PHTHALAZINE; NORADRENALIN; PHTHALAZINE DERIVATIVE; PHTHALAZINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CHLORINATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG HYDROLYSIS; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; RING OPENING; SPECTROPHOTOMETRY; VASCULAR RING;

EID: 84874109627     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0099-6     Document Type: Article

References (19)

1. Badran MM, Abouzid KAM, Hussein MH (2003) Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II). Arch Pharm Res 26:107-113
2. Bansal R, Kumar D, Rosalia Carron R, De la Calle C (2009) Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxphenyl)- 4,5-dihydro-3(2H)-pyridazinone. Eur J Med Chem 44:4441-4447
3. 1-non competitive antagonism. Bioorg Med Chem 11:1353-1361
4. Carella AM, Antonucci G, Conte M, Di-:Pumpo M, Giancola A, Antonucci E (2010) Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review. Curr Diabetes Rev 6:215-221
5. Colotta V, Cecchi L, Catarzi D, Filacchioni G, Galli A, Mori F (1994) Synthesis and structure-activity relationships of 1-aminophthalazinium salts as GABA 318 A receptor antagonists. Eur J Med Chem 29:95-105
6. Del Olmo E, Barboza B, Ybarra M, Lopez-Perez JL, Carron R, Sevilla A, Boselli C, San Feliciano A (2006) Vasorelaxant activity of phthalazinones and related compounds. Bioorg Med Chem Lett 16:2786-2790
7. Demirayak S, Karaburun AC, Kayagil I, Erol K, Sirmagul B (2004a) Some pyridazinone and phthalazinone derivatives and their vasodilator activities. Arch Pharm Res 27:13-18
8. Demirayak S, Karaburun AC, Beis R (2004b) Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. Eur J Med Chem 39:1089-1095
9. Girgis AS et al (2010) Regioselective synthesis and molecular modeling study of vasorelaxant active 7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10- diones. Eur J Med Chem 45:4229-4238
10. Gonec T, Racanska E, Csollei J (2008) Synthesis of 2-{3-[4-(4- fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}phenylcarbamic acid alkylesters and in vitro evaluation of their β-adrenergic and vasodilatative activities. Ces Slov Farm 57:115-118
11. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747-1757
12. Macchia B, Balsamo A, Lapucci A, Martinelli A, Macchia F, Breschi MC, Fantoni B, Martinotti E (1985) An interdisciplinary approach to the design of new structures active at the β-adrenergic receptor. Aliphatic oxime ether derivatives. J Med Chem 28:153-160
13. Marona H, Szkaradek N, Kubacka M, Bednarski M, Filipek B, Cegla M, Szneler E (2008) Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors. Arch Pharm (Weinheim) 341:90-98
14. Matsuda Y, Akita H, Terashima M, Shiga N, Kanazawa K, Yokohama M (2000) Carvediol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J 140:753-759
15. Panjrath GS, Messerli FH (2006) Beta-blockers for primary prevention in hypertension: era bygone? Prog Cardiovasc Dis 49:76-87
16. Racanska E, Maruniak M, Tumova I, Sedlarova E (2010) In vitro pharmacological evaluation of new phenylpiperazine derivatives of phenylcarbamic acid on their basic cardiovascular functions. Acta Fac Pharm Univ Com LVII:1-9
17. 3- antagonists. Bioorg Med Chem 11:4921-4931
18. Toda N (2003) Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics. Pharmacol Ther 100:215-234
19. Yamaguchi M, Kamei K, Koga T, Akima M, Kuroki T, Ohi N (1993) Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones. J Med Chem 36:4052-4060